It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
This paper sets out the main findings from two rounds of interviews with senior representatives from the UK’s urban development industry: the third and final phase of a 3-year pilot, Moving Health Upstream in Urban Development’ (UPSTREAM). The project had two primary aims: firstly, to attempt to value economically the health cost-benefits associated with the quality of urban environments and, secondly, to interview those in control of urban development in the UK in order to reveal the potential barriers to, and opportunities for, the creation of healthy urban environments, including their views on the use of economic valuation of (planetary) health outcomes. Much is known about the ‘downstream’ impact of urban environments on human and planetary health and about how to design and plan healthy towns and cities (‘midstream’), but we understand relatively little about how health can be factored in at key governance tipping points further ‘upstream’, particularly within dominant private sector areas of control (e.g. land, finance, delivery) at sub-national level. Our findings suggest that both public and private sector appeared well aware of the major health challenges posed by poor-quality urban environments. Yet they also recognized that health is not factored adequately into the urban planning process, and there was considerable support for greater use of non-market economic valuation to help improve decision-making. There was no silver bullet however: 110 barriers and 76 opportunities were identified across a highly complex range of systems, actors and processes, including many possible points of targeted intervention for economic valuation. Eight main themes were identified as key areas for discussion and future focus. This findings paper is the second of two on this phase of the project: the first sets out the rationale, approach and methodological lessons learned.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Pilkington, Paul 2 ; Williams, Ben 2 ; Ige, Janet 2 ; Prestwood, Emily 3 ; Hunt, Alistair 4 ; Eaton, Eleanor 4 ; Scally, Gabriel 5 1 University of Bristol, Daniel Black + Associates | db+a, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603)
2 UWE Bristol, Bristol, UK (GRID:grid.6518.a) (ISNI:0000 0001 2034 5266)
3 University of Birmingham, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
4 University of Bath, Bath, UK (GRID:grid.7340.0) (ISNI:0000 0001 2162 1699)
5 University of Bristol, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603); Gabriel Scally Public Health Associates, Bristol, UK (GRID:grid.5337.2)





